ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 55 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -41.7% | 12,615 | -35.8% | 0.00% | – |
| Q4 2021 | $12,000 | -95.5% | 19,636 | -91.9% | 0.00% | – |
| Q2 2021 | $266,000 | +109.4% | 241,991 | +300.6% | 0.00% | – |
| Q1 2019 | $127,000 | +2.4% | 60,404 | +70.7% | 0.00% | – |
| Q1 2018 | $124,000 | +34.8% | 35,382 | +68.8% | 0.00% | – |
| Q4 2017 | $92,000 | +61.4% | 20,955 | +42.6% | 0.00% | – |
| Q3 2015 | $57,000 | -50.4% | 14,694 | -46.2% | 0.00% | – |
| Q2 2015 | $115,000 | +7.5% | 27,331 | +0.2% | 0.00% | – |
| Q1 2015 | $107,000 | -75.3% | 27,266 | -61.1% | 0.00% | – |
| Q4 2014 | $433,000 | +9.9% | 70,098 | -16.7% | 0.00% | – |
| Q3 2014 | $394,000 | -3.7% | 84,162 | -1.0% | 0.00% | – |
| Q2 2014 | $409,000 | -2.4% | 85,050 | +29.1% | 0.00% | – |
| Q1 2014 | $419,000 | – | 65,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |